ARQT R&D Expenses
Arcutis Biotherapeutics Inc · R&D Expenses
ARQT R&D Expenses
Latest reported$91.04Mperiod ending
ARQT TTM R&D Expenses ($17.94M → $91.04M)
TTM R&D Expenses
High-resolution chart · PNG
ARQT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 91,037,000 | |
| 90,135,000 | |
| 77,051,000 | |
| 71,080,000 | |
| 70,977,000 | |
| 70,822,000 | |
| 76,420,000 | |
| 85,715,000 | |
| 92,450,000 | |
| 98,371,000 | |
| 110,575,000 | |
| 120,677,000 | |
| 164,172,000 | |
| 177,158,000 | |
| 182,435,000 | |
| 201,116,000 | |
| 171,989,000 | |
| 164,549,000 | |
| 145,558,000 | |
| 120,374,000 | |
| 112,513,000 | |
| 111,757,000 | |
| 115,308,000 | |
| 98,691,000 | |
| 78,296,000 | |
| 55,501,000 | |
| 36,522,000 | |
| 31,112,000 | |
| 25,845,000 | |
| 21,387,000 | |
| 17,940,000 |